Success Metrics

Clinical Success Rate
86.2%

Based on 162 completed trials

Completion Rate
86%(162/188)
Active Trials
9(4%)
Results Posted
31%(51 trials)
Terminated
26(11%)

Phase Distribution

Ph phase_2
63
28%
Ph phase_4
38
17%
Ph not_applicable
63
28%
Ph early_phase_1
5
2%
Ph phase_1
16
7%
Ph phase_3
42
18%

Phase Distribution

21

Early Stage

63

Mid Stage

80

Late Stage

Phase Distribution227 total trials
Early Phase 1First-in-human
5(2.2%)
Phase 1Safety & dosage
16(7.0%)
Phase 2Efficacy & side effects
63(27.8%)
Phase 3Large-scale testing
42(18.5%)
Phase 4Post-market surveillance
38(16.7%)
N/ANon-phased studies
63(27.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.1%

162 of 195 finished

Non-Completion Rate

16.9%

33 ended early

Currently Active

9

trials recruiting

Total Trials

229

all time

Status Distribution
Active(11)
Completed(162)
Terminated(33)
Other(23)

Detailed Status

Completed162
Terminated26
unknown23
Recruiting7
Withdrawn7
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
229
Active
9
Success Rate
86.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (2.2%)
Phase 116 (7.0%)
Phase 263 (27.8%)
Phase 342 (18.5%)
Phase 438 (16.7%)
N/A63 (27.8%)

Trials by Status

recruiting73%
unknown2310%
terminated2611%
completed16271%
active_not_recruiting21%
not_yet_recruiting21%
withdrawn73%

Recent Activity

Clinical Trials (229)

Showing 20 of 229 trialsScroll for more
NCT07836712Phase 2

Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer

Not Yet Recruiting
NCT01787409Not Applicable

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Active Not Recruiting
NCT05045066Early Phase 1

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Recruiting
NCT02553447Not Applicable

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Completed
NCT04094688Phase 3

Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Active Not Recruiting
NCT03188796Phase 3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Recruiting
NCT03406897Phase 1

Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients

Completed
NCT04621500Phase 2

Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans

Completed
NCT02563015Not Applicable

Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition?

Terminated
NCT05216419Phase 4

Prevention of Postoperative Hypocalcemia of Oral Vitamin D Supplementation Before Total Thyroidectomy

Completed
NCT06301178Phase 1

Effect of Vitamin D Injection on Hypertrophic Scars and Keloids

Completed
NCT06847373Not Applicable

Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity

Recruiting
NCT01974245Phase 2

Supplementation With Cholecalciferol in Dialysis Patients

Completed
NCT06866561Not Applicable

The Effect of Aerobic Exercise on Bone Turnover Markers in Postmenopausal Patients

Completed
NCT03742505Phase 3

Rapid Normalization of Vitamin D Deficiency in PICU

Completed
NCT04167111Not Applicable

Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease

Withdrawn
NCT06571344

Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management

Recruiting
NCT05860270Phase 4

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Recruiting
NCT06508242Phase 4

Effects Of Vitamin D On Bone, Muscle, And Adipose Tissue In Obese Subjects

Recruiting
NCT03475225Phase 3

Vitamine D in Drug Resistant Epilepsy

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
229